News & Updates

Nearly 3 percent of the general population demonstrate greater-than-expected values of forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC), which are both indicative of a better lung function, according to a recent study in Austria.

The multikinase inhibitor anlotinib appears to have promising antitumour activity in the treatment of locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma while having an acceptable safety profile, as shown in a phase II study.

Treatment with single or multiple doses of ceftazidime-avibactam (CAZ-AVI) results in favourable clinical outcomes and is well tolerated in hospitalized neonates and young infants with suspected or confirmed bacterial infections, according to a phase IIa study presented at IDWeek 2023.

Coffee drinking may put brakes on kidney function decline over time as compared with nonconsumption, with coffee intake conferring a protective effect on the risk of chronic kidney disease in a dose-dependent fashion, especially among individuals with diabetes, as shown in a study.